患者对癌症化疗不良影响的认知:来自巴勒斯坦的横截面研究
Ayah Maqdasawi1, Rawan Ghanayiem1, Marwa Khalaf1
1Department of Medicine, Faculty of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine.
BMC cancer
|July 6, 2025
概括
巴勒斯坦的癌症患者经历了显著的化疗副作用,如软弱和脱发. 长时间的化疗会增加副作用,而老年和女性性别与特定的副作用模式有关.
科学领域:
- 在瘤学瘤学.
- 患者报告的结果
- 临床药房 临床药房
背景情况:
- 患者对化疗副作用的认识有所不同.
- 影响意识的因素包括沟通,教育,癌症类型和化疗方案.
- 这项研究调查了巴勒斯坦的现实化疗副作用.
研究的目的:
- 评估西岸,巴勒斯坦癌症患者的化疗诱导的不良影响.
- 为了确定这些副作用的关键预测因素.
- 为量身定制的患者护理和干预提供信息.
主要方法:
- 从2023年1月到12月在巴勒斯坦医院进行的横截面研究.
- 接受化疗的266名癌症患者填写了一份经过验证的问卷.
- 审查了电子病历;进行了描述性统计和回归分析.
主要成果:
- 报告的疲软 (91.7%),脱发 (88.0%) 和头 (87.2%) 的高患病率.
- 更长的化疗疗程持续时间预测了发烧,和虚弱的增加.
- 年龄较大与较低的发烧和皮肤毒性相关;女性性别与较多的虚弱,脱发和有关.
结论:
- 在巴勒斯坦癌症患者中观察到大量的化疗副作用负担.
- 化疗持续时间显著影响不良反应的频率.
- 考虑到患者人口统计和治疗的个性化干预措施对于优化护理和生活质量至关重要.
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
329
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
329
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
456
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
456
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
371
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
371
Nursing Ethical Principles II
1.4K
Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
1.4K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
265
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
265
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K


